Literature DB >> 16512222

Chemical fingerprinting of valeriana species: simultaneous determination of valerenic acids, flavonoids, and phenylpropanoids using liquid chromatography with ultraviolet detection.

Andres Navarrete1, Bharathi Avula, Young-Whan Choi, Ikhlas A Khan.   

Abstract

The roots and rhizomes of various valeriana species are currently used as a sleeping aid or mild sedative. A liquid chromatography method has been developed that permits the analysis of chlorogenic acid, lignans, flavonoids, valerenic acids, and valpotrates in various valerian samples. The best results were obtained with a Phenomenex Luna C18(2) column using gradient elution with a mobile phase consisting of water and 0.05% phosphoric acid and 2-100% acetonitrile-methanol (1 + 1) with 0.05% phosphoric acid. The flow rate was 0.8 mL/min and ultraviolet detection was at 207, 225, 254, 280, and 325 nm. Different valerian species and commercial products showed remarkable quantitative variations. Chlorogenic acid (0.2-1.2%), 3 lignans, linarin (0.002-0.24%), and valepotriates were detected in all the valeriana species analyzed. Highest amounts of valerenic acids were detected in V. officinalis L., trace amounts in V. sitchensis, and none in the other species analyzed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16512222

Source DB:  PubMed          Journal:  J AOAC Int        ISSN: 1060-3271            Impact factor:   1.913


  8 in total

1.  Aqueous and Ethanolic Valeriana officinalis Extracts Change the Binding of Ligands to Glutamate Receptors.

Authors:  Lisa M Del Valle-Mojica; José M Cordero-Hernández; Giselle González-Medina; Igmeris Ramos-Vélez; Nairimer Berríos-Cartagena; Bianca A Torres-Hernández; José G Ortíz
Journal:  Evid Based Complement Alternat Med       Date:  2010-12-02       Impact factor: 2.629

2.  HPLC-based activity profiling approach for the discovery of GABAA receptor ligands using an automated two microelectrode voltage clamp assay on Xenopus oocytes.

Authors:  Hyun Jung Kim; Igor Baburin; Sophia Khom; Steffen Hering; Matthias Hamburger
Journal:  Planta Med       Date:  2008-04       Impact factor: 3.352

Review 3.  Selection and characterization of botanical natural products for research studies: a NaPDI center recommended approach.

Authors:  Joshua J Kellogg; Mary F Paine; Jeannine S McCune; Nicholas H Oberlies; Nadja B Cech
Journal:  Nat Prod Rep       Date:  2019-08-14       Impact factor: 13.423

4.  The anxiolytic effects of a Valerian extract is based on valerenic acid.

Authors:  Axel Becker; Falko Felgentreff; Helmut Schröder; Beat Meier; Axel Brattström
Journal:  BMC Complement Altern Med       Date:  2014-07-28       Impact factor: 3.659

5.  Valerian inhibits rat hepatocarcinogenesis by activating GABA(A) receptor-mediated signaling.

Authors:  Anna Kakehashi; Ayumi Kato; Naomi Ishii; Min Wei; Keiichirou Morimura; Shoji Fukushima; Hideki Wanibuchi
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

6.  Transcriptome and metabolome analysis in shoot and root of Valeriana fauriei.

Authors:  Yun Ji Park; Xiaohua Li; Seung Jae Noh; Jae Kwang Kim; Soon Sung Lim; Nam Il Park; Soonok Kim; Yeon Bok Kim; Young Ock Kim; Sang Won Lee; Mariadhas Valan Arasu; Naif Abdullah Al-Dhabi; Sang Un Park
Journal:  BMC Genomics       Date:  2016-04-23       Impact factor: 3.969

7.  Expression of Terpenoid Biosynthetic Genes and Accumulation of Chemical Constituents in Valeriana fauriei.

Authors:  Yun Ji Park; Mariadhas Valan Arasu; Naif Abdullah Al-Dhabi; Soon Sung Lim; Yeon Bok Kim; Sang Won Lee; Sang Un Park
Journal:  Molecules       Date:  2016-05-27       Impact factor: 4.411

Review 8.  Valerian: no evidence for clinically relevant interactions.

Authors:  Olaf Kelber; Karen Nieber; Karin Kraft
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-30       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.